BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 23078025)

  • 1. The potential of ghrelin in the treatment of cancer cachexia.
    Argilés JM; Stemmler B
    Expert Opin Biol Ther; 2013 Jan; 13(1):67-76. PubMed ID: 23078025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new look at an old drug for the treatment of cancer cachexia: megestrol acetate.
    Argilés JM; Anguera A; Stemmler B
    Clin Nutr; 2013 Jun; 32(3):319-24. PubMed ID: 23395103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ghrelin: from discovery to cancer cachexia therapy.
    Molfino A; Formiconi A; Rossi Fanelli F; Muscaritoli M
    Curr Opin Clin Nutr Metab Care; 2014 Sep; 17(5):471-6. PubMed ID: 24905862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokines and cancer anorexia cachexia syndrome.
    Bennani-Baiti N; Davis MP
    Am J Hosp Palliat Care; 2008; 25(5):407-11. PubMed ID: 18403577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emergence of ghrelin as a treatment for cachexia syndromes.
    DeBoer MD
    Nutrition; 2008 Sep; 24(9):806-14. PubMed ID: 18725076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of ghrelin on anorexia in tumor-bearing mice with eicosanoid-related cachexia.
    Wang W; Andersson M; Iresjö BM; Lönnroth C; Lundholm K
    Int J Oncol; 2006 Jun; 28(6):1393-400. PubMed ID: 16685441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer cachexia pathophysiology and translational aspect of herbal medicine.
    Suzuki H; Asakawa A; Amitani H; Fujitsuka N; Nakamura N; Inui A
    Jpn J Clin Oncol; 2013 Jul; 43(7):695-705. PubMed ID: 23737606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients.
    Wolf I; Sadetzki S; Kanety H; Kundel Y; Pariente C; Epstein N; Oberman B; Catane R; Kaufman B; Shimon I
    Cancer; 2006 Feb; 106(4):966-73. PubMed ID: 16411208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms involved in muscle wasting in cancer and ageing: cachexia versus sarcopenia.
    Argilés JM; Busquets S; Felipe A; López-Soriano FJ
    Int J Biochem Cell Biol; 2005 May; 37(5):1084-104. PubMed ID: 15743680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of ghrelin and ghrelin analogues in wasting disease.
    Kamiji MM; Inui A
    Curr Opin Clin Nutr Metab Care; 2008 Jul; 11(4):443-51. PubMed ID: 18542005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer cachexia.
    Tisdale MJ
    Curr Opin Gastroenterol; 2010 Mar; 26(2):146-51. PubMed ID: 19918173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathogenesis of cancer cachexia.
    Tisdale MJ
    J Support Oncol; 2003; 1(3):159-68. PubMed ID: 15334872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mediators involved in the cancer anorexia-cachexia syndrome: past, present, and future.
    Argilés JM; Busquets S; García-Martínez C; López-Soriano FJ
    Nutrition; 2005 Sep; 21(9):977-85. PubMed ID: 16043325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Megestrol acetate: its impact on muscle protein metabolism supports its use in cancer cachexia.
    Busquets S; Serpe R; Sirisi S; Toledo M; Coutinho J; Martínez R; Orpí M; López-Soriano FJ; Argilés JM
    Clin Nutr; 2010 Dec; 29(6):733-7. PubMed ID: 20621398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The physiological significance and potential clinical applications of ghrelin.
    Akamizu T; Kangawa K
    Eur J Intern Med; 2012 Apr; 23(3):197-202. PubMed ID: 22385874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of anorexia-cachexia syndrome and rational for treatment with selective ghrelin receptor agonist.
    Esposito A; Criscitiello C; Gelao L; Pravettoni G; Locatelli M; Minchella I; Di Leo M; Liuzzi R; Milani A; Massaro M; Curigliano G
    Cancer Treat Rev; 2015 Nov; 41(9):793-7. PubMed ID: 26386985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ghrelin receptor agonist HM01 mimics the neuronal effects of ghrelin in the arcuate nucleus and attenuates anorexia-cachexia syndrome in tumor-bearing rats.
    Borner T; Loi L; Pietra C; Giuliano C; Lutz TA; Riediger T
    Am J Physiol Regul Integr Comp Physiol; 2016 Jul; 311(1):R89-96. PubMed ID: 27147616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Physiology of sarcopenia. Similarities and differences with neoplasic cachexia (muscle impairments in cancer and ageing)].
    Argilés JM; Busquets S; López-Soriano FJ; Figueras M
    Nutr Hosp; 2006 May; 21 Suppl 3():38-45. PubMed ID: 16768029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of food intake and muscle wasting in cachexia.
    Amitani M; Asakawa A; Amitani H; Inui A
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2179-85. PubMed ID: 23911307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advances in pharmacologic strategies for cancer cachexia.
    Madeddu C; Mantovani G; Gramignano G; Macciò A
    Expert Opin Pharmacother; 2015; 16(14):2163-77. PubMed ID: 26330024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.